NCT03663621 is a clinical trial in Obesity, sponsored by Harvard Pilgrim Health Care.

Who is sponsoring NCT03663621?

NCT03663621 is sponsored by Harvard Pilgrim Health Care.

What condition does NCT03663621 study?

NCT03663621 studies Obesity, Pregnancy Complications.

Is NCT03663621 still recruiting?

NCT03663621 is currently completed. Last updated 30 July 2020.

Last reviewed 2020-07-30 · How we verify

NCT03663621

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prepare - How to Reach Women of Reproductive Age With Obesity to Support Weight Loss Before Pregnancy?

Completed Last updated 30 July 2020

What this trial tests

trial in Obesity in 99 participants. Completed in 15 June 2020.

Timeline

25 January 2018

Primary endpoint
31 August 2019

15 June 2020

Quick facts

Lead sponsor	Harvard Pilgrim Health Care
Status	Completed
Study type	OBSERVATIONAL
Enrollment	99
Start date	25 January 2018
Primary completion	31 August 2019
Estimated completion	15 June 2020
Sites	1 location across United States

Conditions studied

Obesity — all drugs for Obesity →
Pregnancy Complications — all drugs for Pregnancy Complications →

Sponsor

Harvard Pilgrim Health Care — full company profile →

Who can join

Adults 18 to 45, female only, with Obesity or Pregnancy Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Researchers at Harvard Pilgrim Health Care Institute and Massachusetts General Hospital are conducting a study to learn more about how best to reach out to women (age 18-45) who are thinking about a pregnancy in the next couple of years and currently have a BMI greater than 30 kg/m2. Interested participants will be asked to complete a 15-minute survey. The survey will ask some more questions about their prior reproductive health history, opinions and experiences regarding lifestyle, weight and health. After completing the survey, researchers would like to arrange a time to complete a 20- to 30-minute semi-structured interview about their perceived health in the process of planning pregnancy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Reaching women with obesity to support weight loss before pregnancy: feasibility and qualitative assessment.
Simon D, Kaimal AJ, Oken E, Hivert MF. · · 2020 · cited 1× · PMID 32518915 · DOI 10.1177/2633494120909106

Verify or expand the search:

Other recruiting trials for Obesity

Currently open trials in the same condition.

NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting

Other Harvard Pilgrim Health Care trials

Trials by the same sponsor.

NCT06516627 — Front-of-Package Nutrition Labels · NA · completed
NCT06584539 — Eco-labels on Restaurant Menus · NA · completed
NCT06384911 — InvesT1D: Promoting Adolescent Investment in Diabetes Care · NA · recruiting
NCT05423743 — INSPIRE Trial for Abdominal Infections · NA · completed
NCT05423756 — INSPIRE Trial for Skin and Soft Tissue Infections · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03663621 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Harvard Pilgrim Health Care
Last refreshed: 30 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03663621.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing